Indication
Lacosamide UCB is indicated as monotherapy and adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Lacosamide UCB 10 mg/ml, oplossing voor infusieNetherlandsAuthorised
- Lacosamide UCB 10 mg/ml, stroopNetherlandsAuthorised
- Lacosamide UCB 100 mg, filmomhulde tablettenNetherlandsAuthorised
- Lacosamide UCB 150 mg, filmomhulde tablettenNetherlandsAuthorised
- Lacosamide UCB 200 mg, filmomhulde tablettenNetherlandsAuthorised